Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Simulations Plus, Inc.

< Previous 1 2 3 4 5 Next >
News headline image
Simulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science Branch
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus to Be Acquired by Altaris For Approximately $375 Million
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus to Participate in Upcoming Investor Conferences
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Positioned to Capitalize on FDA’s Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus to Participate in Upcoming Investor Conferences
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor® Models with Enhanced AI Drug Design
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Invests in Clinical Development Technology Company Nurocor
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
News headline image
Simulations Plus Releases ADMET Predictor® 13
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.